Drug intelligence / Profile preview

nandrolone

Development stage
Phase 4
Lead developer
Organon
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Nandrolone is a classic anabolic-androgenic steroid (AAS) and a 19-nor derivative of testosterone. It is primarily administered as long-acting esters, most notably nandrolone decanoate, via intramuscular injection. Clinically, nandrolone is valued for its high ratio of anabolic to androgenic activity, allowing it to promote muscle growth, increase bone mineral density, and stimulate erythropoiesis with significantly fewer virilizing side effects compared to testosterone. Its primary mechanism involves binding to and activating the androgen receptor, which modulates gene expression related to protein synthesis and nitrogen retention. It has been used historically for the treatment of various anemias, osteoporosis in postmenopausal women, and breast cancer. Modern clinical investigation focuses on its utility in managing sarcopenia, cancer-associated cachexia, HIV-associated wasting syndrome, and recovery from severe burns or major orthopedic surgeries.

Brand names
Deca-DurabolinRetabolilDeca-DurabolKabolinMetadecNortestron
Other names
19-nortestosteronenortestosteronenandrolone decanoatenandrolone phenylpropionatenandrolone 17b-decanoatenandrolone17b-decanoatenandrolone-17b-decanoate
02

Targets

PR (Progesterone receptor)AR (Adrenergic receptors)

Beyond the preview

Go deeper on nandrolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nandrolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call